<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cereb Cortex</journal-id>
<journal-id journal-id-type="iso-abbrev">Cereb. Cortex</journal-id>
<journal-id journal-id-type="publisher-id">cercor</journal-id>
<journal-title-group>
<journal-title>Cerebral Cortex (New York, NY)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1047-3211</issn>
<issn pub-type="epub">1460-2199</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30059958</article-id>
<article-id pub-id-type="pmc">6611458</article-id>
<article-id pub-id-type="doi">10.1093/cercor/bhy158</article-id>
<article-id pub-id-type="publisher-id">bhy158</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>PTPN11</italic> Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Emily M</given-names>
</name>
<xref ref-type="aff" rid="bhy158af1">1</xref>
<xref ref-type="aff" rid="bhy158af2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6872-9699</contrib-id>
<name>
<surname>Ishak</surname>
<given-names>Alexandra D</given-names>
</name>
<xref ref-type="aff" rid="bhy158af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naylor</surname>
<given-names>Paige E</given-names>
</name>
<xref ref-type="aff" rid="bhy158af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stevenson</surname>
<given-names>David A</given-names>
</name>
<xref ref-type="aff" rid="bhy158af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reiss</surname>
<given-names>Allan L</given-names>
</name>
<xref ref-type="aff" rid="bhy158af1">1</xref>
<xref ref-type="aff" rid="bhy158af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Green</surname>
<given-names>Tamar</given-names>
</name>
<xref ref-type="aff" rid="bhy158af1">1</xref>
<xref ref-type="corresp" rid="bhy158cor1"></xref>
<!--<email>tgreen2@stanford.edu</email>-->
</contrib>
</contrib-group>
<aff id="bhy158af1"><label>1</label>Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA</aff>
<aff id="bhy158af2"><label>2</label>Department of Radiology/Molecular Imaging Program, Stanford University, Stanford, CA, USA</aff>
<aff id="bhy158af3"><label>3</label>Department of Pediatrics–Medical Genetics, Stanford University, Stanford, CA, USA</aff>
<aff id="bhy158af4"><label>4</label>Department of Radiology and Pediatrics, Stanford University, Stanford, CA, USA</aff>
<author-notes>
<corresp id="bhy158cor1">Address correspondence to Tamar Green, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd., Stanford, CA 94305-5795, USA. Email: <email>tgreen2@stanford.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2018-07-27" pub-type="epub">
<day>27</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>7</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>29</volume>
<issue>7</issue>
<fpage>2915</fpage>
<lpage>2923</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="bhy158.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>The Ras-MAPK pathway has an established role in neural development and synaptic signaling. Mutations in this pathway are associated with a collection of neurodevelopmental syndromes, Rasopathies; among these, Noonan syndrome (NS) is the most common (1:2000). Prior research has focused on identifying genetic mutations and cellular mechanisms of the disorder, however, effects of NS on the human brain remain unknown. Here, imaging and cognitive data were collected from 12 children with <italic>PTPN11</italic>-related NS, ages 4.0–11.0 years (8.98 ± 2.33) and 12 age- and sex-matched typically developing controls (8.79 ± 2.17). We observe reduced gray matter volume in bilateral corpus striatum (Cohen’s <italic>d</italic> = −1.0:−1.3), reduced surface area in temporal regions (<italic>d</italic> = −1.8:−2.2), increased cortical thickness in frontal regions (<italic>d</italic> = 1.2–1.3), and reduced cortical thickness in limbic regions (<italic>d</italic> = −1.6), including limbic structures integral to the circuitry of the hippocampus. Further, we find high levels of inattention, hyperactivity, and memory deficits in children with NS. Taken together, these results identify effects of NS on specific brain regions associated with ADHD and learning in children. While our research lays the groundwork for elucidating the neural and behavioral mechanisms of NS, it also adds an essential tier to understanding the Ras-MAPK pathway’s role in human brain development.</p>
</abstract>
<kwd-group>
<kwd>ADHD</kwd>
<kwd>hippocampus</kwd>
<kwd>Noonan syndrome</kwd>
<kwd>striatum</kwd>
<kwd>structural imaging</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">The Department of Psychiatry and Behavioral Sciences at Stanford University</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Child Health Research Institute Award from Stanford University</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Child Health and Human Development</named-content>
<named-content content-type="funder-identifier">10.13039/100000071</named-content>
</funding-source>
<award-id>HD049653</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>